Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children

J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, RL Chua, L Thürmann, M Messingschlager, A Seegebarth, B Timmermann, S Klages, M Ralser, B Sawitzki, LE Sander, VM Corman, C Conrad, S Laudi, M Binder, S Trump, R Eils, M.A. Mall, I Lehmann
doi: https://doi.org/10.1101/2021.06.24.21259087

Data Availability

Due to potential risk of de-identification of pseudonymized RNA sequencing data the raw data will be available under controlled access in the EGA repository, [will be added upon completion of peer review/ acceptance]. Count and metadata tables (patient-ID, sex, age, cell type, QC metrics per cell) can be found at FigShare: [will be added upon completion of peer review/ acceptance]. In addition, these data can be further visualized and analyzed in the Magellan COVID-19 data explorer at https://digital.bihealth.org [will be publicly available upon completion of peer review/ acceptance].

Back to top
Posted June 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Pre-activated anti-viral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, RL Chua, L Thürmann, M Messingschlager, A Seegebarth, B Timmermann, S Klages, M Ralser, B Sawitzki, LE Sander, VM Corman, C Conrad, S Laudi, M Binder, S Trump, R Eils, M.A. Mall, I Lehmann
medRxiv 2021.06.24.21259087; doi: https://doi.org/10.1101/2021.06.24.21259087
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area